| scholarly article | Q13442814 |
| P2093 | author name string | Mathumai Kanapathipillai | |
| P2860 | cites work | Polyarginine and its analogues inhibit p53 mutant aggregation and cancer cell proliferation in vitro. | Q50865600 |
| Immunoexpression of tumor suppressor genes p53, p21 WAF1/CIP1 and p27 KIP1 in humam astrocystic tumors. | Q55466958 | ||
| Gain of function of mutant p53 by coaggregation with multiple tumor suppressors | Q57670523 | ||
| Role of acetylcholinesterase in lung cancer | Q26798216 | ||
| Mechanisms of protein-folding diseases at a glance | Q27003095 | ||
| The rebel angel: mutant p53 as the driving oncogene in breast cancer | Q27686765 | ||
| Surfing the p53 network | Q28032484 | ||
| Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's beta-amyloid | Q28267119 | ||
| The p53 pathway: positive and negative feedback loops | Q29617535 | ||
| Inhibition of protein aggregation: supramolecular assemblies of arginine hold the key | Q33305439 | ||
| p53 and apoptosis | Q33547818 | ||
| Targeting p53 for Novel Anticancer Therapy | Q33655329 | ||
| Twenty years of p53 research: structural and functional aspects of the p53 protein | Q33807787 | ||
| Mutant p53: one name, many proteins | Q36070574 | ||
| Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer. | Q36201740 | ||
| A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas | Q36521889 | ||
| Extremolytes: Natural compounds from extremophiles for versatile applications | Q36587672 | ||
| Restoration of wild-type p53 function in human cancer: relevance for tumor therapy. | Q36710840 | ||
| Suppression of protein interactions by arginine: a proposed mechanism of the arginine effects | Q36719963 | ||
| Unfolding, aggregation, and amyloid formation by the tetramerization domain from mutant p53 associated with lung cancer | Q36876885 | ||
| Nanoparticle technologies for cancer therapy | Q37706288 | ||
| The aggregation of mutant p53 produces prion-like properties in cancer | Q38186535 | ||
| Prion-like aggregation of mutant p53 in cancer | Q38207799 | ||
| Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment | Q38211138 | ||
| The impact of the endoplasmic reticulum protein-folding environment on cancer development | Q38241996 | ||
| Amyloidogenicity of p53: a hidden link between protein misfolding and cancer | Q38360401 | ||
| Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation. | Q38723653 | ||
| p21: A Two-Faced Genome Guardian. | Q38747952 | ||
| Dual role of p53 amyloid formation in cancer; loss of function and gain of toxicity. | Q39222212 | ||
| Small stress molecules inhibit aggregation and neurotoxicity of prion peptide 106-126. | Q40044593 | ||
| p53 Aggregates penetrate cells and induce the co-aggregation of intracellular p53. | Q42255562 | ||
| The threads that tie protein-folding diseases | Q42728659 | ||
| The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation | Q44410263 | ||
| Fibrillar aggregates of the tumor suppressor p53 core domain | Q44528743 | ||
| Inhibition of insulin amyloid formation by small stress molecules | Q44849270 | ||
| Role of arginine in the stabilization of proteins against aggregation | Q46393024 | ||
| Inhibition of beta-amyloid peptide aggregation and neurotoxicity by alpha-d-mannosylglycerate, a natural extremolyte | Q46730195 | ||
| Monoclonal Antibodies against Specific p53 Hotspot Mutants as Potential Tools for Precision Medicine | Q47214007 | ||
| Mutant p53 as a target for cancer treatment. | Q48012976 | ||
| Inhibition of p53 Mutant Peptide Aggregation In Vitro by Cationic Osmolyte Acetylcholine Chloride | Q50218287 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P577 | publication date | 2018-05-23 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | Treating p53 Mutant Aggregation-Associated Cancer. | |
| P478 | volume | 10 |
Search more.